211 related articles for article (PubMed ID: 23339190)
1. Novel inhibitors of Rad6 ubiquitin conjugating enzyme: design, synthesis, identification, and functional characterization.
Sanders MA; Brahemi G; Nangia-Makker P; Balan V; Morelli M; Kothayer H; Westwell AD; Shekhar MPV
Mol Cancer Ther; 2013 Apr; 12(4):373-83. PubMed ID: 23339190
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
[TBL] [Abstract][Full Text] [Related]
4. Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin.
Gerard B; Sanders MA; Visscher DW; Tait L; Shekhar MP
Biochim Biophys Acta; 2012 Oct; 1823(10):1686-96. PubMed ID: 22705350
[TBL] [Abstract][Full Text] [Related]
5. RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence.
Haynes B; Gajan A; Nangia-Makker P; Shekhar MP
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165561. PubMed ID: 31639439
[TBL] [Abstract][Full Text] [Related]
6. RAD6B Loss Disrupts Expression of Melanoma Phenotype in Part by Inhibiting WNT/β-Catenin Signaling.
Sarma A; Gajan A; Kim S; Gurdziel K; Mao G; Nangia-Makker P; Shekhar MPV
Am J Pathol; 2021 Feb; 191(2):368-384. PubMed ID: 33181138
[TBL] [Abstract][Full Text] [Related]
7. Rad6B is a positive regulator of beta-catenin stabilization.
Shekhar MP; Gerard B; Pauley RJ; Williams BO; Tait L
Cancer Res; 2008 Mar; 68(6):1741-50. PubMed ID: 18339854
[TBL] [Abstract][Full Text] [Related]
8. RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage.
Haynes BM; Cunningham K; Shekhar MPV
BMC Cancer; 2022 Oct; 22(1):1073. PubMed ID: 36258187
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamides.
Kothayer H; Elshanawani AA; Abu Kull ME; El-Sabbagh OI; Shekhar MP; Brancale A; Jones AT; Westwell AD
Bioorg Med Chem Lett; 2013 Dec; 23(24):6886-9. PubMed ID: 24153206
[TBL] [Abstract][Full Text] [Related]
10. Essential role of T-cell factor/beta-catenin in regulation of Rad6B: a potential mechanism for Rad6B overexpression in breast cancer cells.
Shekhar MP; Tait L; Gerard B
Mol Cancer Res; 2006 Oct; 4(10):729-45. PubMed ID: 17050667
[TBL] [Abstract][Full Text] [Related]
11. RNF168 forms a functional complex with RAD6 during the DNA damage response.
Liu C; Wang D; Wu J; Keller J; Ma T; Yu X
J Cell Sci; 2013 May; 126(Pt 9):2042-51. PubMed ID: 23525009
[TBL] [Abstract][Full Text] [Related]
12. E3 ligase Rad18 promotes monoubiquitination rather than ubiquitin chain formation by E2 enzyme Rad6.
Hibbert RG; Huang A; Boelens R; Sixma TK
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5590-5. PubMed ID: 21422291
[TBL] [Abstract][Full Text] [Related]
13. RAD6B overexpression confers chemoresistance: RAD6 expression during cell cycle and its redistribution to chromatin during DNA damage-induced response.
Lyakhovich A; Shekhar MP
Oncogene; 2004 Apr; 23(17):3097-106. PubMed ID: 14981545
[TBL] [Abstract][Full Text] [Related]
14. Role of a non-canonical surface of Rad6 in ubiquitin conjugating activity.
Kumar P; Magala P; Geiger-Schuller KR; Majumdar A; Tolman JR; Wolberger C
Nucleic Acids Res; 2015 Oct; 43(18):9039-50. PubMed ID: 26286193
[TBL] [Abstract][Full Text] [Related]
15. Role of E2-RING Interactions in Governing RNF4-Mediated Substrate Ubiquitination.
DiBello A; Datta AB; Zhang X; Wolberger C
J Mol Biol; 2016 Nov; 428(23):4639-4650. PubMed ID: 27678051
[TBL] [Abstract][Full Text] [Related]
16. Monoubiquitination of histone H2B is intrinsic to the Bre1 RING domain-Rad6 interaction and augmented by a second Rad6-binding site on Bre1.
Turco E; Gallego LD; Schneider M; Köhler A
J Biol Chem; 2015 Feb; 290(9):5298-310. PubMed ID: 25548288
[TBL] [Abstract][Full Text] [Related]
17. Alternative Splicing of RAD6B and Not RAD6A is Selectively Increased in Melanoma: Identification and Functional Characterization.
Gajan A; Martin CE; Kim S; Joshi M; Michelhaugh SK; Sloma I; Mittal S; Firestine S; Shekhar MPV
Cells; 2019 Nov; 8(11):. PubMed ID: 31683936
[TBL] [Abstract][Full Text] [Related]
18. Structural and Functional Analysis of Ubiquitin-based Inhibitors That Target the Backsides of E2 Enzymes.
Garg P; Ceccarelli DF; Keszei AFA; Kurinov I; Sicheri F; Sidhu SS
J Mol Biol; 2020 Feb; 432(4):952-966. PubMed ID: 31634471
[TBL] [Abstract][Full Text] [Related]
19. Mutations of Rad6 E2 ubiquitin-conjugating enzymes at alanine-126 in helix-3 affect ubiquitination activity and decrease enzyme stability.
Shukla PK; Sinha D; Leng AM; Bissell JE; Thatipamula S; Ganguly R; Radmall KS; Skalicky JJ; Shrieve DC; Chandrasekharan MB
J Biol Chem; 2022 Nov; 298(11):102524. PubMed ID: 36162503
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterization.
Haynes B; Zhang Y; Liu F; Li J; Petit S; Kothayer H; Bao X; Westwell AD; Mao G; Shekhar MPV
Nanomedicine; 2016 Apr; 12(3):745-757. PubMed ID: 26563438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
